Fulcrum Therapeutics
FULC
#7067
Rank
A$0.71 B
Marketcap
A$10.78
Share price
-2.05%
Change (1 day)
125.02%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2025 (TTM): A-$1.84

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.67. In 2024 the company made an earnings per share (EPS) of A-$0.28 an increase over its 2023 EPS that were of A-$2.23.

EPS history for Fulcrum Therapeutics from 2019 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$1.84552.02%
2024A-$0.28-87.34%
2023A-$2.23-36.29%
2022A-$3.508.3%
2021A-$3.23-18.51%
2020A-$3.97-31.36%
2019A-$5.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.44 46.61%๐Ÿ‡บ๐Ÿ‡ธ USA